Resmed announced that it will release its second quarter fiscal 2026 financial and operational results on Thursday, January 29, 2026, immediately after the New York Stock Exchange closes. Management will host a live webcast at 1:30 p.m. PST / 4:30 p.m. EST to discuss quarterly performance, strategic initiatives and forward-looking guidance. International participants can join at 9:30 p.m. GMT (London) or 8:30 a.m. AEDT on Friday in Sydney.

In the first half of fiscal 2026, Resmed has reported a year-over-year increase in device shipments driven by accelerating demand for its cloud-connected CPAP and ventilator solutions. The company now serves over 140 countries and has integrated AI-powered digital health tools into more than 500,000 patient care pathways. Management has highlighted expanding sales in Asia-Pacific, where revenue grew by double digits in the previous quarter.

Resmed will not provide a traditional dial-in phone line; investors must access the earnings call via the webcast link on investor.resmed.com. A replay of the webcast will be available approximately two hours after the event concludes. Additionally, a phone replay (Conference ID: 13757750) can be accessed U.S.: +1 877.660.6853 and International: +1 201.612.7415 from January 29 through February 12, 2026.

With a strong cash position and liquidity to fund ongoing R&D, Resmed plans to further invest in its AI-driven remote patient monitoring platform. However, macroeconomic pressures—such as potential reimbursement changes in key markets and currency exchange volatility—could affect near-term growth. Investors should assess the company’s ability to convert rising device demand into sustainable revenue growth while navigating regulatory headwinds.